ArticleBreast cancer research and treatment2023

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer.

Tom Wei-Wu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.